Literature DB >> 10829524

Resection in chronic pancreatitis: anastomosis with the jejunum or with the stomach?

C Bassi1, M Falconi, T Tihany, R Salvia, A Valerio, E Caldiron, M Abu Hilal, L E Flautner, P Pederzoli.   

Abstract

Even in centers where the first choice in the surgical treatment of chronic pancreatitis is a derivative procedure some selected patients require resection. The most popular solution of gastrointestinal reconstruction still seems to be pancreaticojejunostomy but, the review of the reported experiences, suggests a general trend towards anastomosis with the stomach as a recent policy. A reliable comparison between pancreaticogastrostomy and pancreaticojejunostomy is difficult because the reported series are seldom related to chronic pancreatitis patients only, but are reporting mixed date concerning mainly periampullary cancer. Moreover with only one exception no prospective randomised clinical trails are available; unfortunately the positive trend in favour of pancreaticogastrostomy reported in uncontrolled studies is not confirmed in the randomized setting. Also the comparison between the experiences achieved by the present authors working in centers with different approach to the pancreatic anastomosis does not show statistical significant difference for both morbidity and mortality. In conclusion nowadays the best confidence and experience with any of the two methods represents the basis of choice.

Entities:  

Mesh:

Year:  2000        PMID: 10829524

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  1 in total

1.  A Comparative Study Between Longitudinal Pancreacticojejunostomy v/s Lateral Pancreaticogastrostomy as a Drainage Procedure for Pain Relief in Chronic Pancreatitis Done in a Tertiary Referral Centre of Eastern India.

Authors:  Shyamal Kumar Halder; Prosanta Kumar Bhattacharjee; Partha Bhar; Cinjini Das; Pranjal Pandey; Krishna Pada Rakshit; Anadi Pachaury
Journal:  Indian J Surg       Date:  2012-09-29       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.